US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 15.300
  • -0.080-0.52%
Close Oct 1 16:00 ET
  • 15.400
  • +0.100+0.65%
Pre 08:15 ET
2.54BMarket Cap80.53P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
205.00%25.01M
262.15%29.08M
114.65%16.7M
457.97%85.39M
-8,009.35%-58.96M
162.48%8.2M
76.51%-17.93M
9.25%-114.04M
-3.17%-23.85M
95.74%-727K
Net income from continuing operations
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
-88.03%-27.18M
Operating gains losses
----
----
-29.45%-4.59M
--0
30.94%-1.49M
150.30%1.24M
-1,180.24%-4.34M
-52.08%-3.54M
4.87%-1.54M
-462.92%-2.16M
Depreciation and amortization
45.58%2.57M
1,197.65%5.53M
174.04%5.55M
234.76%1.64M
240.51%1.72M
242.91%1.77M
-17.44%426K
-39.41%2.03M
-8.60%489K
-48.63%506K
Change In working capital
-157.44%-24.68M
-136.03%-5.97M
-52.27%18.13M
228.66%21.71M
-196.11%-10.56M
-1,198.92%-9.59M
-21.65%16.56M
253.04%37.99M
-12.43%6.61M
156.77%10.98M
-Change in receivables
25.83%-10.31M
131.67%2.27M
-1,834.54%-39.27M
-12.59%-7.82M
-181.36%-10.38M
-157.19%-13.91M
-485.07%-7.17M
115.03%2.26M
-88.90%-6.94M
229.50%12.75M
-Change in inventory
-804.90%-27.15M
-3,561.12%-16.65M
-1,292.88%-28.81M
-4,960.32%-15.07M
-1,853.44%-11.22M
-574.68%-3M
-42.26%481K
157.36%2.42M
42.86%310K
118.03%640K
-Change in prepaid assets
-1,152.85%-3.3M
-64.28%-3.67M
-809.42%-17.69M
-171.54%-1.14M
-588.63%-14.06M
-105.48%-263K
-19.91%-2.23M
38.40%2.49M
118.49%1.6M
-228.85%-2.04M
-Change in payables and accrued expense
310.23%15.4M
-52.09%13.98M
224.65%97.97M
367.66%43.37M
2,431.65%21.66M
316.74%3.75M
23.86%29.19M
399.60%30.18M
16.51%9.27M
87.22%-929K
-Change in other current assets
20.84%1.89M
1.91%1.76M
-12.00%5.74M
-57.06%739K
5.05%1.71M
-5.21%1.56M
13.40%1.73M
3.51%6.52M
15.35%1.72M
7.83%1.63M
-Change in other current liabilities
-153.51%-1.21M
32.50%-3.66M
103.42%201K
150.69%1.63M
262.35%1.73M
431.14%2.27M
-13.54%-5.43M
-64.18%-5.88M
-20.80%651K
39.73%-1.07M
Cash from discontinued investing activities
Operating cash flow
205.00%25.01M
262.15%29.08M
114.65%16.7M
457.97%85.39M
-8,009.35%-58.96M
162.48%8.2M
76.51%-17.93M
9.25%-114.04M
-3.17%-23.85M
95.74%-727K
Investing cash flow
Cash flow from continuing investing activities
71.08%-56.19M
-107.29%-14.04M
-56.31%32M
98.04%-347K
120.91%34.11M
-248.20%-194.28M
46.57%192.52M
203.01%73.24M
-124.81%-17.75M
109.88%15.44M
Net PPE purchase and sale
----
----
---50K
--0
----
----
----
--0
--0
----
Net intangibles purchase and sale
----
----
---40M
--0
--0
----
----
--0
--0
--0
Net investment purchase and sale
63.58%-56.19M
-107.29%-14.04M
-1.63%72.05M
98.04%-347K
121.23%34.16M
-176.51%-154.28M
46.57%192.52M
204.66%73.24M
-124.81%-17.75M
109.88%15.44M
Cash from discontinued investing activities
Investing cash flow
71.08%-56.19M
-107.29%-14.04M
-56.31%32M
98.04%-347K
120.91%34.11M
-248.20%-194.28M
46.57%192.52M
203.01%73.24M
-124.81%-17.75M
109.88%15.44M
Financing cash flow
Cash flow from continuing financing activities
-34.92%3.57M
-28.85%1.04M
206.49%25.13M
236.68%5.43M
4,342.86%12.75M
42.99%5.48M
-40.58%1.47M
-54.86%8.2M
-63.02%1.61M
-73.08%287K
Net common stock issuance
-34.92%3.57M
-28.85%1.04M
206.49%25.13M
236.68%5.43M
4,342.86%12.75M
42.99%5.48M
-40.58%1.47M
-54.86%8.2M
-63.02%1.61M
-73.08%287K
Cash from discontinued financing activities
Financing cash flow
-34.92%3.57M
-28.85%1.04M
206.49%25.13M
236.68%5.43M
4,342.86%12.75M
42.99%5.48M
-40.58%1.47M
-54.86%8.2M
-63.02%1.61M
-73.08%287K
Net cash flow
Beginning cash position
-29.04%210.52M
61.20%194.43M
-21.27%120.62M
-35.27%103.96M
-20.29%116.06M
40.81%296.67M
-21.27%120.62M
-53.83%153.21M
59.96%160.61M
-46.61%145.6M
Current changes in cash
84.71%-27.61M
-90.86%16.08M
326.50%73.83M
326.26%90.48M
-180.62%-12.09M
-177.46%-180.6M
206.27%176.05M
81.75%-32.6M
-175.74%-39.99M
108.71%15M
Effect of exchange rate changes
--3K
350.00%5K
-400.00%-18K
-50.00%-12K
-150.00%-4K
--0
-200.00%-2K
-14.29%6K
-900.00%-8K
166.67%8K
End cash Position
57.59%182.9M
-29.04%210.52M
61.20%194.43M
61.20%194.43M
-35.27%103.96M
-20.29%116.06M
40.81%296.67M
-21.27%120.62M
-21.27%120.62M
59.96%160.61M
Free cash flow
178.66%25.01M
262.15%29.08M
79.53%-23.35M
457.97%85.39M
-8,016.23%-59.01M
-142.28%-31.8M
76.51%-17.93M
10.05%-114.04M
-3.17%-23.85M
95.74%-727K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 205.00%25.01M262.15%29.08M114.65%16.7M457.97%85.39M-8,009.35%-58.96M162.48%8.2M76.51%-17.93M9.25%-114.04M-3.17%-23.85M95.74%-727K
Net income from continuing operations 2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M-88.03%-27.18M
Operating gains losses ---------29.45%-4.59M--030.94%-1.49M150.30%1.24M-1,180.24%-4.34M-52.08%-3.54M4.87%-1.54M-462.92%-2.16M
Depreciation and amortization 45.58%2.57M1,197.65%5.53M174.04%5.55M234.76%1.64M240.51%1.72M242.91%1.77M-17.44%426K-39.41%2.03M-8.60%489K-48.63%506K
Change In working capital -157.44%-24.68M-136.03%-5.97M-52.27%18.13M228.66%21.71M-196.11%-10.56M-1,198.92%-9.59M-21.65%16.56M253.04%37.99M-12.43%6.61M156.77%10.98M
-Change in receivables 25.83%-10.31M131.67%2.27M-1,834.54%-39.27M-12.59%-7.82M-181.36%-10.38M-157.19%-13.91M-485.07%-7.17M115.03%2.26M-88.90%-6.94M229.50%12.75M
-Change in inventory -804.90%-27.15M-3,561.12%-16.65M-1,292.88%-28.81M-4,960.32%-15.07M-1,853.44%-11.22M-574.68%-3M-42.26%481K157.36%2.42M42.86%310K118.03%640K
-Change in prepaid assets -1,152.85%-3.3M-64.28%-3.67M-809.42%-17.69M-171.54%-1.14M-588.63%-14.06M-105.48%-263K-19.91%-2.23M38.40%2.49M118.49%1.6M-228.85%-2.04M
-Change in payables and accrued expense 310.23%15.4M-52.09%13.98M224.65%97.97M367.66%43.37M2,431.65%21.66M316.74%3.75M23.86%29.19M399.60%30.18M16.51%9.27M87.22%-929K
-Change in other current assets 20.84%1.89M1.91%1.76M-12.00%5.74M-57.06%739K5.05%1.71M-5.21%1.56M13.40%1.73M3.51%6.52M15.35%1.72M7.83%1.63M
-Change in other current liabilities -153.51%-1.21M32.50%-3.66M103.42%201K150.69%1.63M262.35%1.73M431.14%2.27M-13.54%-5.43M-64.18%-5.88M-20.80%651K39.73%-1.07M
Cash from discontinued investing activities
Operating cash flow 205.00%25.01M262.15%29.08M114.65%16.7M457.97%85.39M-8,009.35%-58.96M162.48%8.2M76.51%-17.93M9.25%-114.04M-3.17%-23.85M95.74%-727K
Investing cash flow
Cash flow from continuing investing activities 71.08%-56.19M-107.29%-14.04M-56.31%32M98.04%-347K120.91%34.11M-248.20%-194.28M46.57%192.52M203.01%73.24M-124.81%-17.75M109.88%15.44M
Net PPE purchase and sale -----------50K--0--------------0--0----
Net intangibles purchase and sale -----------40M--0--0----------0--0--0
Net investment purchase and sale 63.58%-56.19M-107.29%-14.04M-1.63%72.05M98.04%-347K121.23%34.16M-176.51%-154.28M46.57%192.52M204.66%73.24M-124.81%-17.75M109.88%15.44M
Cash from discontinued investing activities
Investing cash flow 71.08%-56.19M-107.29%-14.04M-56.31%32M98.04%-347K120.91%34.11M-248.20%-194.28M46.57%192.52M203.01%73.24M-124.81%-17.75M109.88%15.44M
Financing cash flow
Cash flow from continuing financing activities -34.92%3.57M-28.85%1.04M206.49%25.13M236.68%5.43M4,342.86%12.75M42.99%5.48M-40.58%1.47M-54.86%8.2M-63.02%1.61M-73.08%287K
Net common stock issuance -34.92%3.57M-28.85%1.04M206.49%25.13M236.68%5.43M4,342.86%12.75M42.99%5.48M-40.58%1.47M-54.86%8.2M-63.02%1.61M-73.08%287K
Cash from discontinued financing activities
Financing cash flow -34.92%3.57M-28.85%1.04M206.49%25.13M236.68%5.43M4,342.86%12.75M42.99%5.48M-40.58%1.47M-54.86%8.2M-63.02%1.61M-73.08%287K
Net cash flow
Beginning cash position -29.04%210.52M61.20%194.43M-21.27%120.62M-35.27%103.96M-20.29%116.06M40.81%296.67M-21.27%120.62M-53.83%153.21M59.96%160.61M-46.61%145.6M
Current changes in cash 84.71%-27.61M-90.86%16.08M326.50%73.83M326.26%90.48M-180.62%-12.09M-177.46%-180.6M206.27%176.05M81.75%-32.6M-175.74%-39.99M108.71%15M
Effect of exchange rate changes --3K350.00%5K-400.00%-18K-50.00%-12K-150.00%-4K--0-200.00%-2K-14.29%6K-900.00%-8K166.67%8K
End cash Position 57.59%182.9M-29.04%210.52M61.20%194.43M61.20%194.43M-35.27%103.96M-20.29%116.06M40.81%296.67M-21.27%120.62M-21.27%120.62M59.96%160.61M
Free cash flow 178.66%25.01M262.15%29.08M79.53%-23.35M457.97%85.39M-8,016.23%-59.01M-142.28%-31.8M76.51%-17.93M10.05%-114.04M-3.17%-23.85M95.74%-727K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data